Table 1.
Detailed patients' characteristics.
| Patients' characteristics | n | ||
|---|---|---|---|
| Age (years) | 61 ± 13 | 114 | |
|
| |||
| NYHA class: I/II/III in % (n) | 33% (n = 37)/37% (n = 41)/30% (n = 34) | 112 | |
|
| |||
| Heart failure genesis | Ischemic, % (n) | 39% (n = 44) | 114 |
| Dilated, % (n) | 34% (n = 39) | ||
| Hypertensive, % (n) | 27% (n = 31) | ||
|
| |||
| Body weight (kg) | 91 ± 18 | 106 | |
|
| |||
| Systolic blood pressure (mmHg) | 137 ± 22 | 110 | |
|
| |||
| Diastolic blood pressure (mmHg) | 86 ± 14 | 110 | |
|
| |||
| Comorbidities, % (n) | Hypertension | 82% (n = 93) | 113 |
| Hyperlipidemia | 55% (n = 63) | 114 | |
| Diabetes mellitus | 29% (n = 33) | 113 | |
|
| |||
| Comedication, % (n) | Statin | 57% (n = 63) | 111 |
| ACE-inhibitor | 78% (n = 87) | 111 | |
| Beta-blocker | 97% (n = 109) | 112 | |
|
| |||
| Laboratory values, mean ± SD | Creatinine (μmol/L) | 118 ± 76 | 112 |
| Cholesterol (mmol/) | 5 ± 1.4 | 102 | |
| LDL-cholesterol (mmol/L) | 3 ± 1.2 | 102 | |
| BNP (pg/mL) | 1591 ± 796 | 100 | |
| Hemoglobin (g/dL) | 14 ± 1.9 | 114 | |